Trial · NCT02617446
Outcomes26
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
1 to 20 of 26
Download this page as JSON| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Change in E/Ea Ratio | 24 hours | Intent-to-Treat | Unitless ratio | LEAST_SQUARES_MEAN |
| SECONDARY | Change in LVEF | 24 hours | Intent-to-Treat | % of blood leaving the heart | MEAN |
| SECONDARY | Change in SVI | 24 hours | Intent-to-Treat | mL/m² | LEAST_SQUARES_MEAN |
| SECONDARY | Change in E/A Ratio | 24 hours | Intent-to-Treat | Unitless ratio | LEAST_SQUARES_MEAN |
| SECONDARY | Change in LV End Systolic Volume | 24 hours | Intent-to-Treat | mL | LEAST_SQUARES_MEAN |
| SECONDARY | Change in LV End Diastolic Volume | 24 hours | Intent-to-Treat | mL | LEAST_SQUARES_MEAN |
| SECONDARY | Change in Dyspnea | 24 hours | Intent-to-Treat | Score on a scale (Visual Analog Scale) | MEAN |
| OTHER_PRE_SPECIFIED | Change in cTnT | 24 hours | Intent-to-Treat | ng/L | MEAN |
| OTHER_PRE_SPECIFIED | Change in eGFR | 24 Hours | Safety Population | ml/min/1.73·m² | MEAN |
| OTHER_PRE_SPECIFIED | Participants With Clinically or Hemodynamically Significant Episodes of Arrhythmias | 24 hours | Safety Population | Participants | COUNT_OF_PARTICIPANTS |
| OTHER_PRE_SPECIFIED | PR Interval | 24 Hours | Safety Population | msec | MEAN |
| OTHER_PRE_SPECIFIED | QRS Duration | 24 hours | Safety Population | msec | MEAN |
| OTHER_PRE_SPECIFIED | QTc Interval | 24 Hours | Safety Population | msec | MEAN |
| OTHER_PRE_SPECIFIED | All-Cause Mortality at Day 30 | 30 days | Intent-to-Treat | Participants | COUNT_OF_PARTICIPANTS |
| OTHER_PRE_SPECIFIED | RBC - Shift | Day 3 | Safety Population | Participants | COUNT_OF_PARTICIPANTS |
| OTHER_PRE_SPECIFIED | Hematocrit - Shift | Day 3 | Safety Population | Participants | COUNT_OF_PARTICIPANTS |
| OTHER_PRE_SPECIFIED | Hemoglobin - Shift | Day 3 | Participants | COUNT_OF_PARTICIPANTS | |
| OTHER_PRE_SPECIFIED | White Blood Cells (WBC) - Shift | Day 3 | Safety Population | Participants | COUNT_OF_PARTICIPANTS |
| OTHER_PRE_SPECIFIED | Platelets - Shift | Day 3 | Safety Population | Participants | COUNT_OF_PARTICIPANTS |
| OTHER_PRE_SPECIFIED | Potassium - Shift | Day 3 | Safety Population | Participants | COUNT_OF_PARTICIPANTS |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02617446/outcomes